Vimta Labs Limited

NSE:VIMTALABS India Diagnostics & Research
Market Cap
$214.20 Million
₹18.55 Billion INR
Market Cap Rank
#19571 Global
#965 in India
Share Price
₹415.60
Change (1 day)
-5.43%
52-Week Range
₹411.05 - ₹1155.00
All Time High
₹1155.00
About

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more

Vimta Labs Limited - Asset Resilience Ratio

Latest as of September 2025: 15.99%

Vimta Labs Limited (VIMTALABS) has an Asset Resilience Ratio of 15.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹828.61 Million
Cash + Short-term Investments
Total Assets
₹5.18 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Vimta Labs Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Vimta Labs Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹545.38 Million 10.53%
Short-term Investments ₹283.23 Million 5.47%
Total Liquid Assets ₹828.61 Million 15.99%

Asset Resilience Insights

  • Good Liquidity Position: Vimta Labs Limited maintains a healthy 15.99% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vimta Labs Limited Industry Peers by Asset Resilience Ratio

Compare Vimta Labs Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Vimta Labs Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Vimta Labs Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 3.62% ₹168.85 Million ₹4.67 Billion +0.58pp
2024-03-31 3.04% ₹121.60 Million ₹4.00 Billion +0.54pp
2023-03-31 2.50% ₹90.73 Million ₹3.62 Billion +2.37pp
2022-03-31 0.13% ₹4.06 Million ₹3.07 Billion -0.01pp
2021-03-31 0.14% ₹3.92 Million ₹2.74 Billion -0.24pp
2020-03-31 0.38% ₹9.32 Million ₹2.46 Billion +0.18pp
2019-03-31 0.20% ₹4.70 Million ₹2.37 Billion -0.85pp
2018-03-31 1.05% ₹24.39 Million ₹2.32 Billion +0.58pp
2017-03-31 0.47% ₹10.45 Million ₹2.22 Billion +0.38pp
2011-03-31 0.09% ₹1.58 Million ₹1.77 Billion -12.57pp
2007-03-31 12.66% ₹220.22 Million ₹1.74 Billion -28.47pp
2006-03-31 41.13% ₹702.53 Million ₹1.71 Billion --
pp = percentage points